298 results on '"Thuret, I."'
Search Results
2. Talasemias en el niño
3. Prise en charge pratique des complications aiguës de la drépanocytose chez l’enfant
4. Surveillance de la surcharge en fer myocardique par IRM : utilisation de l’IRM cardiaque combinée à l’IRM hépatique dans une cohorte de patients thalassémiques polytransfusés
5. MRI monitoring of myocardial iron overload: Use of cardiac MRI combined with hepatic MRI in a cohort of multi-transfused patients with thalassaemia
6. Prise en charge actuelle des thalassémies intermédiaires
7. Talasemias en el niño
8. Surcharge en fer d’origine hématologique : validation d’une procédure de dépistage de la surcharge cardiaque par IRM en routine clinique
9. Iron overload of hematological origin: Validation of a screening procedure for cardiac overload by MRI in routine clinical practice
10. Long-term red blood cell exchange in children with sickle cell disease: Manual or automatic?
11. Acute Myeloid Leukemia (AML) in Children: Results of the French Trials
12. Prognostic Factors and Treatment in Pediatric Acute Myeloblastic Leukemia: French Trials
13. Diagnostic biologique de la carence martiale chez l’enfant
14. Place de la thérapie génique dans la bêta-thalassémie
15. Height growth during adolescence and final height after haematopoietic SCT for childhood acute leukaemia: the impact of a conditioning regimen with BU or TBI
16. Health status and quality of life in long-term survivors of childhood leukaemia: the impact of haematopoietic stem cell transplantation
17. CD34+ progenitors are reproducibly recovered in thawed umbilical grafts, and positively influence haematopoietic reconstitution after transplantation
18. Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit – multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group
19. Hipersiderosis infantiles
20. Subcutaneous lymphoblastic lymphomas. Expression of cellular adhesion molecules: 2 cases
21. Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience
22. Haematopoietic stem cell transplantation for β-thalassaemia major: the French experience: P612
23. Geno-identical myeloablative stem cell transplantation to cure sickle-cell anaemia: O396
24. Syndrome d'Evans : étude rétrospective de la société d'hématologie et d'immunologie pédiatrique (36 cas)
25. Hypersidéroses de l'enfant
26. Induction chemotherapy followed by allogeneic bone marrow transplantation or aggressive consolidation chemotherapy in childhood acute myeloblastic leukemia: A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)
27. Infection à VIH de l'enfant : quand débuter le traitement antirétroviral ?
28. Complications thyroïdiennes après greffes de cellules souches hématopoïétiques dans l’enfance
29. Lymphocyte-Predominant Hodgkinʼs Lymphoma in Children: Therapeutic Abstention After Initial Lymph Node Resection—A Study of the French Society of Pediatric Oncology
30. Prognostic Factors and Treatment in Pediatric Acute Myeloblastic Leukemia: French Trials
31. Chélation du fer : les approches actuelles
32. Localized Childhood Hodgkin’s Disease: Response-Adapted Chemotherapy With Etoposide, Bleomycin, Vinblastine, and Prednisone Before Low-Dose Radiation Therapy—Results of the French Society of Pediatric Oncology Study MDH90
33. Iron overload in thalassaemias and genetic haemochromatosis
34. Preliminary report of a toxicity study of hydroxyurea in sickle cell disease
35. PF788 DATA FROM THE FRENCH REGISTRY FOR BETA-THALASSEMIA PATIENTS
36. S140 RESULTS FROM THE PHASE 3 NORTHSTAR‐3 STUDY EVALUATING LENTIGLOBIN GENE THERAPY IN PATIENTS WITH TRANSFUSION‐DEPENDENT β‐THALASSAEMIA AND A β0 OR IVS‐I‐110 MUTATION AT BOTH ALLELES OF THE HBB GENE
37. PF738 MORTALITY IN CHILDREN WITH SICKLE CELL DISEASE IN METROPOLITAN FRANCE FROM 2000 TO 2015
38. S1632 SAFETY AND EFFICACY OF LENTIGLOBIN GENE THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT B-THALASSAEMIA AND NON-B0/B0 GENOTYPES IN THE PHASE 3 NORTHSTAR-2 STUDY
39. Efficacy and safety of LentiGlobin gene therapy in patients with transfusion-dependent β-thalassemia and non-β0/β0 genotypes: Updated results from the completed phase 1/2 Northstar and ongoing phase 3 Northstar-2 studies
40. Prevalence of hepatitis G virus RNA in a monocentric population of French haemophiliacs
41. Persistent hepatitis C virus RNA replication in haemophiliacs: role of co-infection with human immunodeficiency virus
42. Devenir de la grossesse chez les patientes béta-thalassémiques transfusées : données du registre national français
43. Étude de suivi en conditions réelles de traitement des patients pris en charge par déférasirox
44. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel
45. Causes de décès chez les patients drépanocytaires : étude monocentrique de la cohorte marseillaise
46. Information des parents de nouveau-nés AS à la suite du dépistage néonatal de la drépanocytose : expériences lyonnaise et marseillaise (2001–2010)
47. A genetic score for the prediction of beta-thalassemia severity
48. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia
49. Un biomarqueur de la vasculopathie de l’adulte drépanocytaire ?
50. Detection of residual bcr/abl translocation by polymerase chain reaction in chronic myeloid leukaemia patients after bone- marrow transplant
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.